Tools

LUCENTIS® (Genentech, Inc) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment for intraocular treatment.

DOSING INFORMATION:… »   

The U.S. Food and Drug Administration (FDA) has given it’s approval for the drug Actonel (risedronate sodium) to be used… »   

Arthrosurface has received FDA clearance to launch its cartilage surface implant system for the treatment of patello-femoral disease.

… »   

ZymoGenetic has announced that it has filed a lawsuit against Bristol-Myers Squibb for infringement of its patents related to fusion… »   

U.S. authorities said on Thursday they told three companies to stop mass-producing and distributing unapproved medicines to treat asthma, bronchitis… »   

Acting Commissioner of Food and Drugs Andrew C. von Eschenbach, M.D., today announced the formation of an internal FDA Nanotechnology… »   

Acting Commissioner of Food and Drugs Andrew C. von Eschenbach, M.D., today announced the formation of an internal FDA Nanotechnology… »   

The U.S. Food and Drug Administration has approved the first generic version of Effexor (venlafaxine), an important step in the… »   

The Food and Drug Administration (FDA) is seeking information on how the use of a unique identifier system for medical… »   

Drugmaker GlaxoSmithKline Plc. warned on Tuesday that there is an increased risk of cleft lip or cleft palate when the… »